期刊
MOLECULAR ASPECTS OF MEDICINE
卷 33, 期 5-6, 页码 691-703出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.mam.2012.01.002
关键词
Aquaporin (AQP); Drug discovery; Pharmacotherapy; Imaging
资金
- Ministry of Culture, Science, Sports and Technology (MEXT)
- University of Niigata Center for Transdisciplinary Studies
Identification of the aquaporin (AQP) protein family more than twenty years ago has ushered in an era where water and neutral solute trafficking is considered a prime target for pharmacological intervention. Using AQP modulation as a basis for the treatment of human disorders has been suggested by phenotype analysis involving specific AQP-null animals, as well as by pathohistological studies. Based on those reports, a wide variety of disorders, such as cerebral edema, cancer and malaria, are considered indications for AQP modulators. Recent studies have also identified several small molecule AQP modulators that can be used to test those hypotheses in disease models. We believe these studies and compounds form the basis from which future treatments and diagnostic protocols of aquaporin-based disorders will be developed. (C) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据